Eva Coll is a project lead at MiMARK and a researcher in oncology. Eva has experience in the field of mass spectrometry and the identification of protein biomarkers in gynecological fluids. Eva has also interned at the DKFZ German Cancer Research Center.
Eva Coll reports to Marina Rigau, CEO & Co-Founder. Some of their coworkers include Todd Snowden - Business Lead, Antonio Gil - CMO & Co-Founder, and Jordi Petit - Financial Lead.
Current role